Most Active Stories
- Wiley College in Marshall lands National Science Foundation grant
- Health Matters: Medical Controversies and Health Fads
- FaithWorks seeks to get Shreveport-Bossier churches to collaborate
- Shreveport children's author resolves persistent query in 'Billy's Booger'
- KDAQ Web Stream is Back and KLDN is Back On Air!!
Novartis Loses Patent Battle In India
Originally published on Fri April 5, 2013 7:50 am
STEVE INSKEEP, HOST:
NPR's business news starts with a patent ruling that may affect millions.
(SOUNDBITE OF MUSIC)
INSKEEP: The ruling comes from the supreme court of India, a country with a population somewhere north of a billion. The Indian supreme court rejected patent rights claimed by the pharmaceutical giant Novartis. This ruling opens the door for Indian drug makers to produce generic versions of Novartis' lifesaving cancer drugs and will make the medicine more affordable for people in developing nations. Transcript provided by NPR, Copyright NPR.